APVO
Price
$2.17
Change
-$0.09 (-3.98%)
Updated
Aug 11, 11:44 AM (EDT)
Capitalization
7.29M
INO
Price
$1.45
Change
+$0.04 (+2.84%)
Updated
Aug 11, 03:46 PM (EDT)
Capitalization
71.85M
Interact to see
Advertisement

APVO vs INO

Header iconAPVO vs INO Comparison
Open Charts APVO vs INOBanner chart's image
Aptevo Therapeutics
Price$2.17
Change-$0.09 (-3.98%)
Volume$200
Capitalization7.29M
Inovio Pharmaceuticals
Price$1.45
Change+$0.04 (+2.84%)
Volume$1.71K
Capitalization71.85M
APVO vs INO Comparison Chart in %
Loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APVO vs. INO commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and INO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (APVO: $2.26 vs. INO: $1.41)
Brand notoriety: APVO: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 2% vs. INO: 21%
Market capitalization -- APVO: $7.29M vs. INO: $71.85M
APVO [@Biotechnology] is valued at $7.29M. INO’s [@Biotechnology] market capitalization is $71.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 1 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • APVO’s FA Score: 1 green, 4 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, APVO is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 4 TA indicator(s) are bullish while INO’s TA Score has 3 bullish TA indicator(s).

  • APVO’s TA Score: 4 bullish, 3 bearish.
  • INO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APVO is a better buy in the short-term than INO.

Price Growth

APVO (@Biotechnology) experienced а -15.67% price change this week, while INO (@Biotechnology) price change was -1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($71.9M) has a higher market cap than APVO($7.29M). INO YTD gains are higher at: -20.787 vs. APVO (-97.378). APVO has higher annual earnings (EBITDA): -23.79M vs. INO (-93.37M). INO has more cash in the bank: 68.4M vs. APVO (2.14M). APVO has less debt than INO: APVO (4.42M) vs INO (11.3M). INO has higher revenues than APVO: INO (283K) vs APVO (0).
APVOINOAPVO / INO
Capitalization7.29M71.9M10%
EBITDA-23.79M-93.37M25%
Gain YTD-97.378-20.787468%
P/E Ratio0.00N/A-
Revenue0283K-
Total Cash2.14M68.4M3%
Total Debt4.42M11.3M39%
FUNDAMENTALS RATINGS
APVO vs INO: Fundamental Ratings
APVO
INO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9888
P/E GROWTH RATING
1..100
54100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APVO's Valuation (10) in the Biotechnology industry is somewhat better than the same rating for INO (50) in the Medical Specialties industry. This means that APVO’s stock grew somewhat faster than INO’s over the last 12 months.

APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INO (100) in the Medical Specialties industry. This means that APVO’s stock grew similarly to INO’s over the last 12 months.

INO's SMR Rating (99) in the Medical Specialties industry is in the same range as APVO (100) in the Biotechnology industry. This means that INO’s stock grew similarly to APVO’s over the last 12 months.

INO's Price Growth Rating (88) in the Medical Specialties industry is in the same range as APVO (98) in the Biotechnology industry. This means that INO’s stock grew similarly to APVO’s over the last 12 months.

APVO's P/E Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for INO (100) in the Medical Specialties industry. This means that APVO’s stock grew somewhat faster than INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APVOINO
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
76%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RZLT5.810.24
+4.31%
Rezolute
NOEM10.10N/A
N/A
CO2 Energy Transition Corp
LXP8.04-0.05
-0.62%
LXP Industrial Trust
LYB49.06-1.11
-2.21%
LyondellBasell Industries NV
GNPX0.21-0.01
-3.43%
Genprex

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with ENLV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then ENLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
+5.61%
ENLV - APVO
36%
Loosely correlated
+5.93%
GNPX - APVO
33%
Poorly correlated
-3.43%
KROS - APVO
32%
Poorly correlated
+2.77%
IBO - APVO
27%
Poorly correlated
-0.53%
INO - APVO
27%
Poorly correlated
-2.08%
More

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with KROS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
-2.08%
KROS - INO
53%
Loosely correlated
+2.77%
RPTX - INO
51%
Loosely correlated
+0.99%
PCSA - INO
38%
Loosely correlated
+0.39%
CADL - INO
33%
Poorly correlated
+3.08%
IRD - INO
33%
Poorly correlated
-1.83%
More